GB1570958A - Immunogenic product of tetanus toxin - Google Patents

Immunogenic product of tetanus toxin Download PDF

Info

Publication number
GB1570958A
GB1570958A GB31968/77A GB3196877A GB1570958A GB 1570958 A GB1570958 A GB 1570958A GB 31968/77 A GB31968/77 A GB 31968/77A GB 3196877 A GB3196877 A GB 3196877A GB 1570958 A GB1570958 A GB 1570958A
Authority
GB
United Kingdom
Prior art keywords
substance
fragment
vaccine
animal
tetanus toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31968/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1570958A publication Critical patent/GB1570958A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB31968/77A 1976-07-31 1977-07-29 Immunogenic product of tetanus toxin Expired GB1570958A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2634584A DE2634584C3 (de) 1976-07-31 1976-07-31 Atoxisches, immunogenes Produkt aus Tetanus-Toxin

Publications (1)

Publication Number Publication Date
GB1570958A true GB1570958A (en) 1980-07-09

Family

ID=5984461

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31968/77A Expired GB1570958A (en) 1976-07-31 1977-07-29 Immunogenic product of tetanus toxin

Country Status (18)

Country Link
JP (1) JPS5326319A (fr)
AT (1) AT362498B (fr)
AU (1) AU516191B2 (fr)
BE (1) BE857373A (fr)
CA (1) CA1099635A (fr)
DE (1) DE2634584C3 (fr)
DK (1) DK342577A (fr)
EG (1) EG12732A (fr)
FI (1) FI58500C (fr)
FR (1) FR2360315A1 (fr)
GB (1) GB1570958A (fr)
IE (1) IE45539B1 (fr)
IL (1) IL52617A (fr)
IT (1) IT1085660B (fr)
LU (1) LU77874A1 (fr)
NL (1) NL7708279A (fr)
NO (1) NO772704L (fr)
SE (1) SE7708693L (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516442D0 (en) * 1985-06-28 1985-07-31 Wellcome Found Cloned antigen

Also Published As

Publication number Publication date
IT1085660B (it) 1985-05-28
FI58500C (fi) 1981-02-10
JPS5326319A (en) 1978-03-11
DE2634584A1 (de) 1978-02-02
NL7708279A (nl) 1978-02-02
IL52617A0 (en) 1977-10-31
LU77874A1 (fr) 1978-02-02
CA1099635A (fr) 1981-04-21
DE2634584B2 (de) 1979-03-22
FI58500B (fi) 1980-10-31
DK342577A (da) 1978-02-01
FI772305A (fr) 1978-02-01
FR2360315A1 (fr) 1978-03-03
IL52617A (en) 1980-12-31
IE45539L (en) 1978-01-31
AT362498B (de) 1981-05-25
SE7708693L (sv) 1978-02-01
AU516191B2 (en) 1981-05-21
FR2360315B1 (fr) 1980-04-11
IE45539B1 (en) 1982-09-22
DE2634584C3 (de) 1979-11-08
ATA563477A (de) 1980-10-15
NO772704L (no) 1978-02-01
BE857373A (fr) 1978-02-01
EG12732A (en) 1979-09-30
AU2738077A (en) 1979-02-01

Similar Documents

Publication Publication Date Title
Underdown et al. Isolation and characterization of an allergen from short ragweed pollen
US5667787A (en) Purification of a pertussis outer membrane protein
US5840700A (en) Methods of producing transfer factor
US4075193A (en) Process for producing intravenous immune globulin
JPH0561255B2 (fr)
JPH03191789A (ja) 百日咳菌からの69000ダルトンの抗原性タンパク質の精製方法
Slutzky et al. Leishmanial excreted factor: protein-bound and free forms from promastigote cultures of Leishmania tropica and Leishmania donovani
EP0175841B1 (fr) Méthode de production d'un composant de vaccin contre la coqueluche et vaccin combiné d'antigène de coqueluche, de toxoide de la diphtérie et de toxoide du tétanos
IE42760B1 (en) Derivatives of the tetanus toxin, process for their preparation and agents containing them
Attallah et al. Isolation of haptenic material from ragweed pollen
US4200627A (en) Atoxic, immunogenic product of tetanus toxin
GB1570958A (en) Immunogenic product of tetanus toxin
IE41909B1 (en) Derivatives of diphtherial toxin, process for preparin them and agents containing them
US4056614A (en) Immunity depressant medicine
Kuo et al. A new allergen from the perienteric fluid of Ascaris suum with respect to charges
US3542920A (en) Tetanus vaccine and process for preparing it
US3968202A (en) Tetanus antigen and process for its manufacture
Lindahl et al. Binding to erythrocyte membrane glycoproteins and carbohydrate specificity of F41 fimbriae of enterotoxigenic Escherichia coli
US6444211B2 (en) Purification of a pertussis outer membrane protein
Ferreira et al. Mouse C4 (Ss): three-step purification of its C4c fragment and production of a monospecific antiserum
Matheson et al. Serologic relationships between β-lysins of different species
EP0002645B1 (fr) Complexe antigénique de neisseria gonorrhoeae, procédé et vaccin
Gordon et al. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor‐bearer ascites fluid and reactivity with anti‐thy‐1.2 antiserum
US2584093A (en) Method of purifying diphtheria toxoids
Soares et al. An effective toxoid from tetanus toxin prepared by stepwise iodination of purified toxin

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee